Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With ...

Black Diamond Therapeutics (NASDAQ:BDTX) reported encouraging Phase 2 data for its drug candidate BDTX-1535 in the treatment ...

周二，H.C. Wainwright维持了Black Diamond Therapeutics (NASDAQ:BDTX)的买入评级和11.00美元的目标价。这家专注于精准癌症药物的生物技术公司最近公布了BDTX-1535 200mg治疗的初步二期试验结果。

CAMBRIDGE, Mass. - 临床阶段肿瘤公司Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)报告了其药物候选BDTX-1535的初步2期数据,显示在复发/难治性EGFR突变非小细胞肺癌(NSCLC)患者中有promising的临床反应。研究发现,每日200 mg剂量治疗的患者具有良好的耐受性,初步客观缓解率(ORR)为42%。 该试验于2023 ...

Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.

(RTTNews) - Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or refractory non-small cell lung cancer also known as NSCLC, ...

Thedford Volunteer Fire and Rescue responded to a report of a “Black Diamond” fire southwest of Thedford Saturday.

The Shamokin Area High School competition band will host the 57th Black Diamond Tournament of Bands at Kemp Memorial Stadium ...

Emma Coronel, a former beauty queen, was released from prison a year ago, and will now be a runway model at Milan Fashion ...

Black Diamond Therapeutics’ stock price $BDTX jumped more than 15% premarket Monday morning after the company reported its ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.